Unravelling The Mechanism Of MHC Class-I Associated Drug Hypersensitivities
Funder
National Health and Medical Research Council
Funding Amount
$566,308.00
Summary
Some drugs cause adverse reactions that are life threatening. We think these reactions are mediated by killer T cells as they are genetically controlled by immune response genes that normally guide immunity to microbes. We will study immune reactions to the drug abacavir, used to treat HIV (AIDS); allopurinol used to prevent gout and carbamazepine, used to treat epilepsy. The study may also help devise better treatments for patients who experience severe forms of these reactions.
Discovery Early Career Researcher Award - Grant ID: DE150100517
Funder
Australian Research Council
Funding Amount
$360,000.00
Summary
Organocatalysis: A New Horizon for Synthesis of Organic Structures. The current technologies to synthesise organic substances, an important part of human life, often involve the use of excess amounts of reagents or precious and toxic metal catalysts, which incur high production costs and severe environmental impact. This project aims to use organocatalysis, chemical processes catalysed by stable, small, easily accessible, non-metallic organic compounds, to find a solution for these issues. Novel ....Organocatalysis: A New Horizon for Synthesis of Organic Structures. The current technologies to synthesise organic substances, an important part of human life, often involve the use of excess amounts of reagents or precious and toxic metal catalysts, which incur high production costs and severe environmental impact. This project aims to use organocatalysis, chemical processes catalysed by stable, small, easily accessible, non-metallic organic compounds, to find a solution for these issues. Novel organocatalytic methods will be designed and developed in order to promote environmentally friendly, highly efficient and selective chemical procedures for low cost production of laboratory organic substances and application in the industrial synthesis of potential agrochemicals and medicinal agents.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE100100104
Funder
Australian Research Council
Funding Amount
$400,000.00
Summary
Capability for the fabrication and characterisation of mid-infrared photonic materials. The proposed facility will support the development of new glass materials suitable for transmitting and generating light in the mid-infrared spectral region. This research will allow Australia to lead the world in developing new technologies that make use of the mid-infrared region of the electromagnetic spectrum. Particular applications that will flow from this research include the development of new optical ....Capability for the fabrication and characterisation of mid-infrared photonic materials. The proposed facility will support the development of new glass materials suitable for transmitting and generating light in the mid-infrared spectral region. This research will allow Australia to lead the world in developing new technologies that make use of the mid-infrared region of the electromagnetic spectrum. Particular applications that will flow from this research include the development of new optical fibre-based laser sources for defence and surgery, new technologies for detecting and treating cancer, and other in-vivo detection methods.Read moreRead less
Confinement of space based on association of water soluble container molecules. The proposed research addresses the use of water soluble bowl shaped molecules or ions (cavitands) in conjunction with metal ions and crown ether and related cryptand molecules to form molecular capsules, two or more of the components being pre-programmed to assemble thus. The new materials will be unique in supramolecular chemistry, with the associated architectures bearing on materials science, molecular electronic ....Confinement of space based on association of water soluble container molecules. The proposed research addresses the use of water soluble bowl shaped molecules or ions (cavitands) in conjunction with metal ions and crown ether and related cryptand molecules to form molecular capsules, two or more of the components being pre-programmed to assemble thus. The new materials will be unique in supramolecular chemistry, with the associated architectures bearing on materials science, molecular electronics, separation sciences, and drug delivery. The new range of water soluble container molecules that will become accessible as part of this proposal, promises new applications in these areas.Read moreRead less
New Chiral Metal Catalysts; Going Beyond the State of the Art. The synthesis of both natural and unnatural organic compounds in optically active form is a central challenge in chemistry. Because the most important molecules in nature are chiral and of specific handedness, there exists a growing need to access any given organic compound in its optically pure form. Asymmetric catalysis offers the most elegant way to solving this problem and this project will target some of the difficult challenges ....New Chiral Metal Catalysts; Going Beyond the State of the Art. The synthesis of both natural and unnatural organic compounds in optically active form is a central challenge in chemistry. Because the most important molecules in nature are chiral and of specific handedness, there exists a growing need to access any given organic compound in its optically pure form. Asymmetric catalysis offers the most elegant way to solving this problem and this project will target some of the difficult challenges in realising asymmetric synthesis, building new, privileged chiral ligands, opening new catalytic pathways for constructing chiral compounds and understanding the intimate catalytic pathway that enables reactivity and selectivity. This will generate applications across the chemical industries.Read moreRead less
Optimisation Of Antimicrobial Therapy For Severe Bacterial Infections In Neonates And Young Children In Papua New Guinea
Funder
National Health and Medical Research Council
Funding Amount
$943,865.00
Summary
This study aims to provide important information on the way young Papua New Guinean children with serious bacterial infections handle antibiotics, including newer agents that may be required if bacterial resistance is confirmed or increases. The data will be used to optimise treatment, thus reducing mortality and potential adverse drug effects, in PNG nad other tropical countries, and may have implications for the developed world as well.
Molecular Pharmacology Of Chemokine Receptor Signalling In Cancer
Funder
National Health and Medical Research Council
Funding Amount
$371,770.00
Summary
Molecular pharmacology is the study of how hormones, neurotransmitters and pharmaceuticals interact with our cells through receptors, which transfer a signal across the cell membrane to change the function of that cell. Chemokine receptors are recognised to play a role in the development of many cancers. Understanding how these receptors work has enormous implications for improving our ability to develop better anti-cancer treatments with fewer side effects.
DYRK1A As A Novel Target For Glioblastoma Therapies
Funder
National Health and Medical Research Council
Funding Amount
$620,294.00
Summary
Glioblastoma is a form of brain cancer that is currently incurable. We have discovered that switching-off an enzyme called DYRK1A (using ‘DYRK1A inhibitors’) kills glioblastoma cells. This therapeutic advantage is even greater when combined with drugs approved for other cancers. This project will develop new DYRK1A inhibitors and examine a novel combination treatment for glioblastoma patients. This could initiate a novel therapy that could significantly extend patients’ lives.
Design and synthesis of novel lanthanoid complexes for the fabrication of light emitting devices. There is a huge and still growing economy centred around the design and fabrication of low-cost Light Emitting Devices (LEDs), as demonstrated by the excess of US$1.3 billion invested in this field between 2000 and 2007. Nations focused on the production of new and more efficient materials will be at the forefront of these emerging technologies. The major thrust of this proposal, the design and prep ....Design and synthesis of novel lanthanoid complexes for the fabrication of light emitting devices. There is a huge and still growing economy centred around the design and fabrication of low-cost Light Emitting Devices (LEDs), as demonstrated by the excess of US$1.3 billion invested in this field between 2000 and 2007. Nations focused on the production of new and more efficient materials will be at the forefront of these emerging technologies. The major thrust of this proposal, the design and preparation of luminescent rare earths complexes, and their use for the fabrication of LEDS, represent a good opportunity for Australia to access this growing market. Read moreRead less